Risk Of Severe Hepatic Injury In Patients With Invasive Candidiasis

See also
Status	Clinical Trial	Phase
Terminated	`NCT01982071` - A Study to Evaluate the Efficacy and Safety of Micafungin Against Invasive Candidiasis or Candidemia	Phase 4
Completed	`NCT02163889` - Serial Therapeutic and Antifungal Monitoring Protocol
Completed	`NCT02244606` - Oral Ibrexafungerp (SCY-078) vs Standard-of-Care Following IV Echinocandin in the Treatment of Invasive Candidiasis	Phase 2
Recruiting	`NCT01438216` - Anidulafungin Pharmacokinetics in Intensive Care Unit Patients	N/A
Not yet recruiting	`NCT01249313` - Risk Factor and Outcome of Candidemia	N/A
Completed	`NCT00940017` - A Study To Assess The Anidulafungin And Voriconazole Concentration In Lung Following Intravenous Administration In Healthy Subjects	Phase 4
Completed	`NCT00105144` - Study of Micafungin in Patients With Invasive Candidiasis or Candidemia	Phase 3
Completed	`NCT03667690` - Study of Rezafungin Compared to Caspofungin in Subjects With Candidemia and/or Invasive Candidiasis	Phase 3
Completed	`NCT03604705` - An Efficacy and Safety Study of APX001 in Non-Neutropenic Patients With Candidemia	Phase 2
Completed	`NCT00607763` - Study of Mycamine® in Infants and Toddlers With Fungal Infections to Evaluate Safety and Blood Levels of the Drug	Phase 1
Completed	`NCT00608335` - Study of Mycamine® in Children With Fungal Infections to Evaluate Safety and Blood Levels of the Drug	Phase 1
Recruiting	`NCT04147975` - Assessment of Assay for Rapid Identification of Bloodstream Infections From Whole Blood
Completed	`NCT01734525` - Negative Beta Glucan in ICU Patients	Phase 4
Withdrawn	`NCT01622595` - UARK 2009-99 A Non-interventional Observational Study of Infectious Complications in Cancer Patients	N/A
Completed	`NCT03363841` - Open-Label Study to Evaluate the Efficacy and Safety of Oral Ibrexafungerp (SCY-078) in Patients With Candidiasis Caused by Candida Auris (CARES)	Phase 3
Completed	`NCT03799172` - Echinocandins Versus Azoles for Candidemia Treatment
Completed	`NCT01406093` - Early- and Late-onset Candidemia	N/A
Completed	`NCT00670657` - CRITIC - Treatment of Candidemia and Invasive Candidiasis	Phase 4
Completed	`NCT00113191` - Safety and Efficacy of Veronate® Versus Placebo in Preventing Nosocomial Staphylococcal Sepsis in Premature Infants	N/A
Recruiting	`NCT04368559` - Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation	Phase 3

NCT number	NCT01213823
Study type	Observational
Source	Pfizer
Contact
Status	Terminated
Phase	Phase 4
Start date	September 2008
Completion date	May 2011

Risk Of Severe Hepatic Injury In Patients With Invasive Candidiasis Treated With Echinocandins

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms